Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison
Lebrikizumab plus TCS was comparable to dupilumab plus TCS across all efficacy endpoints at week 16.
Authors
- Martín Dossenbach
- Bülent Akmaz
- Gaia Gallo
- Yousef Binamer (ORCID: https://orcid.org/0000-0003-0948-7102)
- Raj Chovatiya (ORCID: https://orcid.org/0000-0001-6510-399X)
- L. Puig (ORCID: https://orcid.org/0000-0001-6083-0952)
- Mark G. Kirchhof (ORCID: https://orcid.org/0000-0002-4015-8377)
- Yuxin Ding (ORCID: https://orcid.org/0000-0001-8968-9147)
- Leon Kircik (ORCID: https://orcid.org/0000-0002-0831-2151)
- Chao Yang (ORCID: https://orcid.org/0000-0002-6598-208X)
- Gleison Vieira Duarte (ORCID: https://orcid.org/0000-0003-4160-5447)
- Tiago Torres (ORCID: https://orcid.org/0000-0003-0404-0870)
- Lucia Seminario‐Vidal (ORCID: https://orcid.org/0000-0002-6004-2451)
- April W. Armstrong (ORCID: https://orcid.org/0000-0002-6892-6286)
- Jonathan I. Silverberg
Institutions
- University of Southern California (US)
- Alfaisal University (SA)
- University of Ottawa (CA)
- Eli Lilly (United States) (US)
- Universidade do Porto (PT)
- Rosalind Franklin University of Medicine and Science (US)
- George Washington University (US)
- Instituto Federal de Educação, Ciência e Tecnologia Baiano (BR)
- Ottawa Hospital (CA)
- King Faisal Specialist Hospital & Research Centre (SA)
- Hospital de Sant Pau (ES)
- Almirall (Spain) (ES)
- Hospital de Santo António (PT)
- Center for Clinical Research (United States) (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1007/s13555-025-01620-x
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Biogen
- Celgene
- Canadian Dermatology Foundation
- Valeant Pharmaceuticals International
- Celldex Therapeutics
- Mylan
- Castle Biosciences
- Galderma
- Sun Pharma
- LEO Pharma
- Samsung